Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
AIDS and Behavior
Published in: AIDS and Behavior 10/2019

01-10-2019 | Human Immunodeficiency Virus | Original Paper

Location of Pre-exposure Prophylaxis Services Across New York City Neighborhoods: Do Neighborhood Socio-demographic Characteristics and HIV Incidence Matter?

Authors: Byoungjun Kim, Denton Callander, Ralph DiClemente, Chau Trinh-Shevrin, Lorna E. Thorpe, Dustin T. Duncan

Published in: AIDS and Behavior | Issue 10/2019

Login to get access

Abstract

Despite an increasing pre-exposure prophylaxis (PrEP) use among populations at highest risk of HIV acquisition, comprehensive and easy access to PrEP is limited among racial/ethnic minorities and low-income populations. The present study analyzed the geographic distribution of PrEP providers and the relationship between their location, neighborhood characteristics, and HIV incidence using spatial analytic methods. PrEP provider density, socio-demographics, healthcare availability, and HIV incidence data were collected by ZIP-code tabulation area in New York City (NYC). Neighborhood socio-demographic measures of race/ethnicity, income, insurance coverage, or same-sex couple household, were not associated with PrEP provider density, after adjusting for spatial autocorrelation, and PrEP providers were located in high HIV incidence neighborhoods (P < 0.01). These findings validate the need for ongoing policy interventions (e.g. public health detailing) vis-à-vis PrEP provider locations in NYC and inform the design of future PrEP implementation strategies, such as public health campaigns and navigation assistance for low-cost insurance.
Literature
1.
Centers for Disease Control Prevention. HIV surveillance report, 2016. Atlanta: CDC; 2017.
2.
Hall HI, An Q, Tang T, Song RG, Chen M, Green T, et al. Prevalence of diagnosed and undiagnosed HIV infection-United States, 2008–2012. MMWR. 2015;64(24):657–62.PubMedPubMedCentral
3.
Singh S, Song RG, Johnson AS, McCray E, Hall HI. HIV incidence, prevalence, and undiagnosed infections in US men who have sex with men. Ann Int Med. 2018;168(10):685–94.PubMedCrossRef
4.
5.
Duncan DT, Kawachi I. Neighborhoods and health. Oxford: Oxford University Press; 2018.CrossRef
6.
7.
Pellowski JA, Kalichman SC, Matthews KA, Adler N. A pandemic of the poor social disadvantage and the US HIV epidemic. Am Psychol. 2013;68(4):197–209.PubMedPubMedCentralCrossRef
8.
Acevedo-Garcia D. Residential segregation and the epidemiology of infectious diseases. Soc Sci Med. 2000;51(8):1143–61.PubMedCrossRef
9.
10.
Grant RM, Lama JR, Anderson PL, McMahan V, Liu AY, Vargas L, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. New Engl J Med. 2010;363(27):2587–99.PubMedCrossRef
11.
Thigpen MC, Kebaabetswe PM, Paxton LA, Smith DK, Rose CE, Segolodi TM, et al. Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in botswana. New Engl J Med. 2012;367(5):423–34.PubMedCrossRef
12.
Choopanya K, Martin M, Suntharasamai P, Sangkum U, Mock PA, Leethochawalit M, et al. Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet. 2013;381(9883):2083–90.PubMedCrossRef
13.
McCormack S, Dunn DT, Desai M, Dolling DI, Gafos M, Gilson R, et al. Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (Proud): effectiveness results from the pilot phase of a pragmatic open-label randomised trial. Lancet. 2016;387(10013):53–60.PubMedPubMedCentralCrossRef
14.
Huang YLA, Zhu WM, Smith DK, Harris N, Hoover KW. HIV preexposure prophylaxis, by race and ethnicity-United States, 2014–2016. MMWR. 2018;67(41):1147–50.PubMedPubMedCentral
15.
Smith DK, Van Handel M, Grey J. Estimates of adults with indications for HIV pre-exposure prophylaxis by jurisdiction, transmission risk group, and race/ethnicity, United States, 2015. Ann Epidemiol. 2018;28(12):850–7.PubMedCrossRef
16.
Kirby T, Thornber-Dunwell M. Uptake of prep for HIV slow among MSM. Lancet. 2014;383(9915):399–400.PubMedCrossRef
17.
Golub SA, Gamarel KE, Rendina HJ, Surace A, Lelutiu-Weinberger CL. From efficacy to effectiveness: facilitators and barriers to prep acceptability and motivations for adherence among MSM and transgender women in New York city. Aids Patient Care STDs. 2013;27(4):248–54.PubMedPubMedCentralCrossRef
18.
Lelutiu-Weinberger C, Golub SA. Enhancing prep access for black and latino men who have sex with men. JAIDS. 2016;73(5):547–55.PubMed
19.
Elopre L, Kudroff K, Westfall AO, Overton ET, Mugavero MJ. The right people, right places, and right practices: disparities in prep access among African American men, women, and MSM in the deep south. JAIDS. 2017;74(1):56–9.PubMed
20.
Cohen SE, Vittinghoff E, Bacon O, Doblecki-Lewis S, Postle BS, Feaster DJ, et al. High Interest in preexposure prophylaxis among men who have sex with men at risk for HIV infection: baseline data from the US prep demonstration project. JAIDS. 2015;68(4):439–48.PubMed
21.
Bush S, Magnuson D, Rawlings MK, Hawkins T, McCallister S, Mera Giler R. Racial characteristics of Ftc/Tdf for pre-exposure prophylaxis (Prep) users in the US. ASM Microbe/ICAAC; Boston, MA2016.
22.
Snowden JM, Chen YH, McFarland W, Raymond HF. Prevalence and characteristics of users of pre-exposure prophylaxis (Prep) among Men who have sex with men, San Francisco, 2014 in a cross-sectional survey: implications for disparities. Sex Transm Infect. 2017;93(1):52–5.PubMedCrossRef
23.
Chen YT, Kolak M, Duncan DT, Schumm P, Michaels S, Fujimoto K, et al. Neighbourhoods, networks and pre-exposure prophylaxis awareness: a multilevel analysis of a sample of young black men who have sex with men. Sex Transm Infect. 2019;95(3):228–35.PubMedCrossRef
24.
LeSage JP, Pace RK. Introduction to spatial econometrics. Boca Raton: Chapman and Hall/CRC; 2009.CrossRef
25.
Ward MD, Gleditsch KS. Spatial regression models. 2nd ed. Los Angeles: SAGE; 2019.
26.
Waller LA, Gotway CA. Applied spatial statistics for public health data. Hoboken: Wiley; 2004.CrossRef
27.
Bailey TC, Gatrell AC. Interactive spatial data analysis. Essex: Longman Scientific & Technical; 1995.
28.
29.
Siegler AJ, Wirtz S, Weber S, Sullivan PS. Developing a web-based geolocated directory of HIV pre-exposure prophylaxis-providing clinics: the prep locator protocol and operating procedures. JMIR Public Health Surveill. 2017;3(3):e58.PubMedPubMedCentralCrossRef
30.
New York: New York City Department of Health and Mental Hygiene. HIV epidemiology and field services program. HIV surveillance annual report, 2016. 2017.
31.
32.
Duncan DT, Castro MC, Blossom JC, Bennett GG, Gortmaker SL. Evaluation of the positional difference between two common geocoding methods. Geospatial Health. 2011;5(2):265–73.PubMedCrossRef
33.
Duncan DT, Kawachi I, Kum S, Aldstadt J, Piras G, Matthews SA, et al. A spatially explicit approach to the study of socio-demographic inequality in the spatial distribution of trees across boston neighborhoods. Spat Demogr. 2014;2(1):1–29.PubMedCrossRef
34.
Duncan DT, Kawachi I, White K, Williams DR. The geography of recreational open space: influence of neighborhood racial composition and neighborhood poverty. J Urban Health. 2013;90(4):618–31.PubMedCrossRef
35.
Duncan DT, Aldstadt J, Whalen J, White K, Castro MC, Williams DR. Space, race, and poverty: spatial inequalities in walkable neighborhood Amenities? Demogr Res. 2012;26:409–48.PubMedPubMedCentralCrossRef
36.
Duncan DT, Castro MC, Gortmaker SL, Aldstadt J, Melly SJ, Bennett GG. Racial differences in the built environment—body mass index relationship? A geospatial analysis of adolescents in urban neighborhoods. Int J Health Geogr. 2012;11:11.PubMedPubMedCentralCrossRef
37.
Haining R. Bivariate correlation with spatial data. Geogr Anal. 1991;23(3):210–27.CrossRef
38.
Anselin L, Bera AK, Florax R, Yoon MJ. Simple diagnostic tests for spatial dependence. Reg Sci Urban Econ. 1996;26(1):77–104.CrossRef
39.
Anselin L. Lagrange multiplier test diagnostics for spatial dependence and spatial heterogeneity. Geogr Anal. 1988;20(1):1–17.CrossRef
40.
Bozdogan H. Model selection and Akaike information criterion (AIC)—the general-theory and its analytical extensions. Psychometrika. 1987;52(3):345–70.CrossRef
41.
Sclove SL. Application of model-selection criteria to some problems in multivariate-analysis. Psychometrika. 1987;52(3):333–43.CrossRef
42.
Florax RJGM, Folmer H, Rey SJ. Specification searches in spatial econometrics: the relevance of Hendry’s methodology. Reg Sci Urban Econ. 2003;33(5):557–79.CrossRef
43.
Smith DK, Toledo L, Smith DJ, Adams MA, Rothenberg R. Attitudes and program preferences of African-American urban young adults about pre-exposure prophylaxis (Prep). AIDS Educ Prev. 2012;24(5):408–21.PubMedCrossRef
44.
Kelley CF, Kahle E, Siegler A, Sanchez T, del Rio C, Sullivan PS, et al. Applying a prep continuum of care for men who have sex with men in Atlanta, Georgia. Clin Infect Dis. 2015;61(10):1590–7.PubMedPubMedCentralCrossRef
45.
Ard KL, Edelstein ZR, Bolduc P, Daskalakis D, Gandhi AD, Krakower DS, et al. Public health detailing for human immunodeficiency virus pre-exposure prophylaxis. Clin Infect Dis. 2019;68(5):860–4.PubMedCrossRef
46.
Bauermeister JA, Meanley S, Pingel E, Soler JH, Harper GW. Prep awareness and perceived barriers among single young men who have sex with men. Curr HIV Res. 2014;11(7):520–7.CrossRef
47.
King HL, Keller SB, Giancola MA, Rodriguez DA, Chau JJ, Young JA, et al. Pre-exposure prophylaxis accessibility research and evaluation (prepare study). AIDS Behav. 2014;18(9):1722–5.PubMedPubMedCentralCrossRef
48.
Krakower D, Ware N, Mitty JA, Maloney K, Mayer KH. HIV providers’ perceived barriers and facilitators to implementing pre-exposure prophylaxis in care settings: a qualitative study. AIDS Behav. 2014;18(9):1712–21.PubMedPubMedCentralCrossRef
49.
Taylor SW, Mayer KH, Elsesser SM, Mimiaga MJ, O’Cleirigh C, Safren SA. Optimizing content for pre-exposure prophylaxis (prep) counseling for men who have sex with men: perspectives of prep users and high-risk prep Na < Ve men. AIDS Behav. 2014;18(5):871–9.CrossRefPubMedCentral
50.
Galea JT, Kinsler JJ, Salazar X, Lee SJ, Giron M, Sayles JN, et al. Acceptability of pre-exposure prophylaxis as an HIV prevention strategy: barriers and facilitators to pre-exposure prophylaxis uptake among at-risk peruvian populations. Int J STD AIDS. 2011;22(5):256–62.PubMedPubMedCentralCrossRef
51.
Krieger N, Williams DR, Moss NE. Measuring social class in US public health research: concepts, methodologies, and guidelines. Annu Rev Public Health. 1997;18(1):341–78.PubMedCrossRef
52.
Duncan DT, Kawachi I, Subramanian SV, Aldstadt J, Melly SJ, Williams DR. Examination of how neighborhood definition influences measurements of youths access to tobacco retailers: a methodological note on spatial misclassification. Am J Epidemiol. 2014;179(3):373–81.PubMedCrossRef
53.
Wong D. The Modifiable Areal Unit Problem (Maup). In: Fotheringham AS, Rogerson PA, editors. The sage handbook of spatial analysis. London: SAGE; 2009. p. 105–23.
54.
Krieger N, Waterman P, Chen JT, Soobader M-J, Subramanian SV, Carson R. Zip code caveat: bias due to spatiotemporal mismatches between zip codes and US census-defined geographic areas—the public health disparities geocoding project. Am J Public Health. 2002;92(7):1100–2.PubMedPubMedCentralCrossRef
55.
New York City Department of Health and Mental Hygiene. HIV surveillance annual report, 2017. New York: New York City Department of Health and Mental Hygiene; 2019.
Metadata
Title
Location of Pre-exposure Prophylaxis Services Across New York City Neighborhoods: Do Neighborhood Socio-demographic Characteristics and HIV Incidence Matter?
Authors
Byoungjun Kim
Denton Callander
Ralph DiClemente
Chau Trinh-Shevrin
Lorna E. Thorpe
Dustin T. Duncan
Publication date
01-10-2019
Publisher
Springer US
Published in
AIDS and Behavior / Issue 10/2019
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-019-02609-2

Other articles of this Issue 10/2019

AIDS and Behavior 10/2019 Go to the issue

OriginalPaper

Factors Associated with Improved HIV/AIDS Treatment Outcomes: Comparing two Major ART Service Delivery Models in Vietnam

Original Paper

Limited Knowledge and Lack of Screening for Acute HIV Infection at Primary Care Clinics in High-Prevalence Communities of New York City

Original Paper

Factors Associated with PrEP Refusal Among Transgender Women in Northeastern Brazil

Original Paper

Interest in Pre-exposure Prophylaxis (PrEP) for HIV is Limited Among Women in a General Obstetrics & Gynecology Setting

Substantive Review

The PrEP Care Continuum and Black Men Who Have Sex with Men: A Scoping Review of Published Data on Awareness, Uptake, Adherence, and Retention in PrEP Care

Original Paper

Factors Associated with PrEP Support and Disclosure Among YMSM and Transgender Individuals Assigned Male at Birth in Chicago
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits